Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35,910Revenue (TTM) $M21,903Net Margin (%)1.3Altman Z-Score0.8
Enterprise Value $M74,128EPS (TTM) $0.1Operating Margin %9.7Piotroski F-Score3
P/E(ttm)3,713Beneish M-Score-2.3Pre-tax Margin (%)3.5Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %4.7Quick Ratio0.7Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-2.8Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow8.3y-y EBITDA Growth Rate %-32.2ROA % (ttm)0.4Higher Current Ratio y-yN
Dividend Yield %3.8PEG--ROE % (ttm)0.1Less Shares Outstanding y-yN
Payout Ratio %1,943Shares Outstanding M1,015ROIC % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TEVA is held by these investors:



TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about TEVA:

    News about teva:

    Articles On GuruFocus.com
    David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017 
    Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
    Naltrexone Showing More Potential in Drug Addiction Treatment Market Feb 05 2017 
    John Paulson's Bargain Stock Jan 30 2017 
    Teva: Good Value, Questionable Management? Jan 02 2017 
    Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
    4 Stocks Reach Their 3-Year Low Prices Dec 31 2016 
    10 for 2017! Investment Picks for the New Year Dec 23 2016 
    Teva Is a Hold Nov 30 2016 
    Buy Health Care Now? It All Depends on the Election Nov 07 2016 

    More From Other Websites
    Teva Is Expected to See a Fall in Its Profit Margins in 2017 Feb 23 2017
    Teva Is Expected to Witness a Modest Revenue Rise in 2017 Feb 23 2017
    What Analysts Recommend for Teva Pharmaceutical in 2017 Feb 23 2017
    Billionaire Andreas Halvorsen’s Viking Global Cuts Losses and Dumps Southwestern Energy and Teva... Feb 23 2017
    Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical... Feb 22 2017
    TEVA PHARMACEUTICAL INDUSTRIES LTD Financials Feb 22 2017
    Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug Feb 21 2017
    Teva Shares Get a Boost in Early Trading Feb 21 2017
    Billionaire Value Investor Michael Price Adds Specialty Retailer and a REIT to Its 13F Portfolio Feb 20 2017
    This Keeps Driving Sanofi’s Growth Feb 20 2017
    Parsabiv Is Expected to Boost Amgen’s Revenues in 2017 Feb 17 2017
    David Tepper Invests Heavily in Pharma in 4th Quarter Feb 16 2017
    What's Driving Lilly's (LLY) Shares after 2016 Decline? Feb 16 2017
    Multinationals learn the limits of being big Feb 16 2017
    Teva Files 2016 Annual Report on Form 20-F Feb 15 2017
    Teva seeks CEO with pharma background to lead recovery efforts Feb 13 2017
    Drugmaker Teva says Israel probing kickback allegations Feb 08 2017
    Drugmaker Teva says Israel probing kickback allegations Feb 07 2017
    Teva CEO exits in ongoing crisis of confidence at drugmaker Feb 07 2017
    Teva CEO exits in ongoing crisis of confidence at drugmaker Feb 07 2017
    Teva says Israel probing same issues as U.S. bribery case Feb 07 2017
    Teva names interim CEO, new chairman as Vigodman steps down Feb 06 2017
    Teva names interim CEO, new chairman as Vigodman steps down Feb 06 2017
    Asian shares mostly higher on strong manufacturing data Jan 31 2017
    As Teva wins U.S. approval for GSK Advair copy, main fight yet to come Jan 30 2017
    As Teva wins US approval for GSK Advair copy, main fight yet to come Jan 30 2017
    Teva Announces Completion of Sale of UK and Ireland Actavis Assets and Operations Following European... Jan 09 2017
    Israeli drugmaker Teva fined $519 mn in US for foreign bribes Dec 22 2016
    Israeli drugmaker Teva fined $519 mn in US for foreign bribes Dec 22 2016
    ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA’S DECENTRALIZED PROCEDURE FOR... Dec 19 2016
    Actavis UK raised drug prices 12,000 pct, watchdog finds Dec 16 2016
    Exclusive - Teva investigating allegations by tipster of bribery in Romania Dec 07 2016
    Teva Receives Positive Outcome for COPAXONE® Label in Europe Dec 06 2016
    Teva names Bhattacharjee as generics group head, replacing Olafsson Dec 05 2016
    Teva names Bhattacharjee as generics group head, replacing Olafsson Dec 05 2016
    Teva drugs help boost Mayne revenue Nov 28 2016
    Teva drugs help Mayne to strong start Nov 28 2016
    Teva trims 2016 outlook on drug launch delays Nov 15 2016
    Israeli billionaire Nacht bets big money on another Teva in healthcare Nov 15 2016
    ISS Mexico wins contract with Teva Pharmaceuticals Nov 10 2016
    Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs Oct 17 2016
    Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products... Oct 17 2016
    Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership Oct 06 2016
    Deals of the day- Mergers and acquisitions Oct 05 2016
    Teva to sell Allergan's generics business in UK, Ireland for $769 million Oct 05 2016
    Teva to sell Allergan's generics business in UK, Ireland for $769 million Oct 05 2016
    Teva to sell Allergan's generics business in UK, Ireland for $769 million Oct 05 2016
    Teva Announces Sale of UK and Ireland Actavis Assets and Operations Oct 05 2016
    Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an... Sep 20 2016
    Teva, Intel to develop wearable tech for Huntington's disease Sep 15 2016
    Teva, Intel to develop wearable technology for Huntington's disease Sep 15 2016
    Teva and UGG Unveil Hybrid Collection Sep 15 2016
    Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London Sep 07 2016
    MDxHealth and Teva Pharmaceuticals Sign Distribution Agreement for SelectMDx in Israel Aug 31 2016
    Teva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International... Aug 30 2016
    Teva Pharm eyes more acquisitions after buying Allergan's generics business Aug 04 2016
    Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA Aug 03 2016
    Allergan to sell Anda drug distribution business to Teva Aug 03 2016
    Teva completes $40 bn purchase of Allergan generics arm Aug 02 2016
    Teva completes $40 bn purchase of Allergan generics arm Aug 02 2016
    Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
    Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
    Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
    Five high-grade issuers announce deals Jul 20 2016
    TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States Jun 27 2016
    Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd. Jun 16 2016
    Mesoblast shares tank after Teva exit Jun 14 2016
    Mesoblast shares drop on outlook concerns Jun 13 2016
    Dr. Reddy’s to acquire product portfolio from TEVA for US Market Jun 11 2016
    Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan Jun 11 2016
    Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan Jun 11 2016
    Teva Announces New Collaboration with GRAMMY Nominated Artist Jhené Aiko Jun 01 2016
    Takeda and Teva Establish "Teva Takeda Yakuhin Ltd." in Japan Mar 31 2016
    Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources Mar 09 2016
    Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources Mar 09 2016
    Teva to buy Mexico's Rimsa for $2.3 bln Oct 01 2015
    Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
    Chinese market dive pressures US stocks Jul 27 2015
    Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
    Teva to lift bid for Mylan: report Jul 06 2015
    Exclusive - Teva poised to raise its stake in Mylan -sources Jun 02 2015
    Teva to pay $1.2 bn fine to settle US antitrust case May 28 2015
    Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy Apr 29 2015
    US STOCKS-Wall St reverses course to trade lower as health stocks drag Apr 27 2015
    Generic drugmaker Mylan goes hostile in bid for Perrigo Apr 24 2015
    Generic drugmaker Teva makes $40 billion offer for rival Mylan Apr 21 2015
    Top Mylan shareholders seek deal with Teva - sources Apr 21 2015
    Generic drugmaker Mylan offers $29 billion for Perrigo Apr 08 2015
    U.S. Supreme Court rules for Teva over MS drug patent Jan 20 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)